Reproducibility of Lymphocyte-To-Monocyte Ratio (LMR), Neutrophil-To-Lymphocyte Ratio (NLR) and Platelet-To-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer

Cieszymierz Gawiński,Wojciech Michalski,Lucjan Wyrwicz

DOI: https://doi.org/10.21203/rs.3.rs-1243808/v1

2022-01-21

Abstract:Abstract Rectal cancer constitutes over one-third of all colorectal cancers (CRC) and is one of the leading cause of cancer-related death in developed countries. Treatment modalities applied in locally advanced tumors differ substantially among research centers. In order to identify high-risk patients and better adjust the therapy new markers are needed. Systemic inflammatory response (SIR) markers such as LMR, NLR and PLR have been proved highly prognostic in many malignancies, including CRC; however, they lack proper validation. In our study we assessed the reproducibility of LMR, NLR and PLR. Sixty patients with locally advanced rectal cancer treated in Maria-Sklodowska Curie National Research Institute of Oncology in Warsaw, Poland between 08.2017 and 12.2020 were prospectively enrolled in the study. Three consecutive blood morphology tests of each patient within a median period of 21 days were obtained before start of the treatment. LMR, NLR and PLR calculated at two time-points were correlated with the coefficient of 0.776, 0.696 and 0.751 (p<0.005 in all measurements), respectively. Cohen’s Kappa statistic for the extent of agreement between the 1st and the 2nd measurement for LMR was κ = 0.59 (95% CI, 0.39-0.79), p < 0.001. For NLR the Kappa was κ = 0.45 (95% CI, 0.22-0.68), p < 0.001 and for PLR κ = 0.53 (95% CI, 0.32-0.75. Mean percentage change between the third and the first measurement of lymphocytes, monocytes, neutrophils and platelets count ranged from -5.59–4.76% and the standard error from 2.0 to 3.9. In conclusion, SIR markers are moderately reproducible, easily obtained biomarkers with potential application in clinical practice.